SRI KRISHNA PHARMACEUTICALS LTD

SRI KRISHNA PHARMACEUTICALS LTD (India) holds 12 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 12 active ingredients and is linked to 3 FDA-registered manufacturing sites. 17 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SRI KRISHNA PHARMACEUTICALS LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sri-krishna-pharmaceuticals-ltd

Overview

SRI KRISHNA PHARMACEUTICALS LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering ACETAMINOPHEN USP; BUTORPHANOL TARTRATE USP; DIMETHYL FUMARATE USP; DOMPERIDONE PH EUR; ENALAPRIL MALEATE USP PROCESS-II; FOLIC ACID USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which SRI KRISHNA PHARMACEUTICALS LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

SRI KRISHNA PHARMACEUTICALS LTD holds 12 active (15 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • TOLVAPTANActive2026-04-14
  • ENALAPRIL MALEATE USP PROCESS-IIActive2024-07-16
  • DIMETHYL FUMARATE USPActive2024-05-29
  • GLYBURIDE USPActive2013-04-19
  • GLIPIZIDE USPActive2012-05-07
  • BUTORPHANOL TARTRATE USPActive2012-01-17
  • DOMPERIDONE PH EURActive2010-12-13
  • FUROSEMIDE USPActive2009-12-22
  • MECLIZINE HYDROCHLORIDE USPActive2009-12-15
  • SODIUM PHENYLBUTYRATE USPActive2006-06-30
  • FOLIC ACID USPActive2004-08-16
  • ACETAMINOPHEN USPActive2002-02-06
  • SODIUM PHENYLBUTYRATE GRANULES 100% (KRISOSPB-100)Inactive2010-10-25
  • ACETAMINOPHEN GRANULES DC 90%Inactive2004-08-16
  • ACETAMINOPHEN GRANULES DC 90% (KRISOPAP 90F)Inactive2004-05-27

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to SRI KRISHNA PHARMACEUTICALS LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

17 FDA enforcement records linked to this company.

  • 4832025-06-27

    Investigations of discrepancies, failures

  • 4832025-06-27

    Rejecting When Specifications Not Met

  • 4832025-06-27

    Extent of discrepancy, failure investigations

  • 4832025-06-27

    Drug products - samples representative, identified properly

  • 4832025-06-27

    Absence of Written Procedures

  • 4832025-06-27

    Records not made readily available to FDA

  • 4832025-06-27

    Complaint Investigation/Follow-Up Findings

  • 4832025-06-27

    Cleaning / Sanitizing / Maintenance

  • 4832023-05-19

    Computer control of master formula records

  • 4832023-05-19

    Buildings not maintained in good state of repair

  • 4832023-05-19

    Cleaning / Sanitizing / Maintenance

  • 4832023-05-19

    Master production and control records, procedure

  • 4832023-05-19

    Investigations of discrepancies, failures

  • 4832023-05-19

    Absence of Written Procedures

  • 4832023-05-19

    Procedures not in writing, fully followed

  • 4832023-05-19

    Complaint Handling Procedure

  • warning_letter2016-04-01

    FDA Warning Letter (drug product)

For suppliers

Is this SRI KRISHNA PHARMACEUTICALS LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.